Workflow
Mueller Water Products (NYSE:MWA) Earnings Call Presentation
2025-11-10 12:00
Financial Performance Highlights - FY2025 net sales reached $1,430 million, with a 5-year CAGR of 8.2%[12] - Adjusted EBITDA for FY2025 was $326.2 million, representing 22.8% of net sales and a 5-year CAGR of 11.3%[12] - Free cash flow for FY2025 amounted to $172 million[12] - Net debt stood at $20.1 million as of September 30, 2025, with a net debt to adjusted EBITDA ratio of 0.1x[12] - Q4 Fiscal 2025 net sales were $380.8 million, a 9.4% increase year-over-year[71] - Q4 Fiscal 2025 adjusted EBITDA was $91.8 million, a 26.6% increase year-over-year[71] - Q4 Fiscal 2025 adjusted net income per diluted share was $0.38, a 72.7% increase year-over-year[71] Strategic Priorities and Investments - The company aims to identify a total of 18 billion gallons of water loss by 2029 through EchoShore® leak detection[20] - Capital expenditures are expected to increase to 4% to 5% of net sales over the next 3 years[77] - The company has allocated $95 million to share repurchases since FY2019, including $15 million in FY2025, with $65 million remaining authorization on the share repurchase program as of September 30, 2025[93] FY2026 Outlook - Consolidated net sales are projected to be between $1,450 million and $1,470 million, representing a year-over-year growth of 1.4% to 2.8%[87] - Adjusted EBITDA is expected to range from $345 million to $350 million, indicating a year-over-year growth of 5.8% to 7.3%[87]
CBAK Energy(CBAT) - 2025 Q3 - Earnings Call Presentation
2025-11-10 12:00
Investor Presentation (NASDAQ: CBAT) Technology, Inc. November 2025 CBAK Energy ©2025 CBAK. All Rights Reserved. The First Chinese Li-ion Battery Manufacturer Listed in NASDAQ Disclaimer Powering a Sustainable Life with Electricity Disclaimers and Other Important Information This presentation (the "Presentation") about CBAK Energy Technology, Inc. (the "Company" or "CBAK") is dated as of March 2021. It is information in a summary form and does not purport to be complete. The data contained herein is derived ...
Standard Lithium (NYSEAM:SLI) Earnings Call Presentation
2025-11-10 11:00
Company Overview - Standard Lithium aims to be a leading low-cost, sustainable U S lithium producer [22] - The company plans for near-term commercial-scale production using innovative technologies on its Arkansas and Texas assets [24] - The company is developing projects with global partners, benefiting from stakeholder and regulatory support [26] Resource and Project Highlights - The Smackover Formation is a premier lithium resource in North America, with concentrations up to 616 mg/L in Arkansas and 806 mg/L in East Texas [27] - The South West Arkansas (SWA) Project has been awarded a $225 million grant from the U S Department of Energy (DOE) [27] - The SWA Project is targeting commercial production in 2028, with an initial capacity of 22,500 tonnes per annum (TPA) of lithium carbonate [30, 38] - The East Texas Projects have the potential for over 100,000 TPA LCE production across three projects [38] Market and Economics - Global lithium demand is projected to reach 2.8 million tonnes of lithium carbonate equivalent (LCE) by 2030 [27] - The SWA Project DFS indicates a $1.7 billion unlevered pre-tax NPV and a 20% pre-tax IRR, with a total CAPEX of $1.449 billion [40]
Merck & Co (NYSE:MRK) Earnings Call Presentation
2025-11-10 00:01
American Heart Association 2025 Investor Presentation November 9, 2025 Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA This presentation of Merck & Co., Inc., Rahway, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company's management and are subject to significant risks and uncertainties. ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) Earnings Call Presentation
2025-11-09 01:00
Kidney Program Updates at the American Society of Nephrology Kidney Week 2025 November 8, 2025 ©2025 Vertex Pharmaceuticals Incorporated ©2025 Vertex Pharmaceuticals Incorporated Presentation intended for the investment community Agenda Welcome Susie Lisa, CFA, Senior Vice President, Investor Relations, Vertex Pharmaceuticals Kidney portfolio Reshma Kewalramani, M.D., President and Chief Executive Officer, Vertex Pharmaceuticals RUBY-3 late breaking data recap James A. Tumlin, M.D., Professor of Medicine in ...
ViaSat(VSAT) - 2026 Q2 - Earnings Call Presentation
2025-11-07 22:30
Financial Performance - Viasat reported Q2 FY2026 revenue of $1.141 billion, a 2% increase compared to $1.122 billion in Q2 FY2025[20, 23] - Adjusted EBITDA for Q2 FY2026 was $385 million, a 3% increase compared to $375 million in Q2 FY2025[21, 23] - The company generated $69 million in free cash flow during the quarter, a $58 million improvement year-over-year[22] - For the twelve months ended September 30, 2025, Viasat generated $147 million in free cash flow[22] - Operating cash flow increased by 18% YoY, from $239 million to $282 million[23] Segment Performance - Communication Services (CS) revenue grew 1% YoY, reaching $837 million in Q2 FY26[23, 27] - Defense and Advanced Technologies (DAT) segment revenues grew 3% YoY, reaching $304 million in Q2 FY26[23, 39] - CS segment Adjusted EBITDA increased 6% YoY to $337 million[23, 29] - DAT segment Adjusted EBITDA declined 15% YoY to $48 million[23, 41] Awards and Backlog - Total awards increased 17% YoY to $1.498 billion[19, 23] - CS segment awards increased 35% YoY to $1.031 billion[23, 26] - DAT awards declined 9% YoY to $467 million[23, 37] - DAT segment backlog grew 31% to a record $1.2 billion[23, 36, 45]
HEI(HE) - 2025 Q3 - Earnings Call Presentation
2025-11-07 21:30
HEI 3Q 2025 Financial Results November 7, 2025 Non-GAAP Financial Information See Appendix for definition of Core Earnings and Core EPS. 2 Continued Progress on Key Strategic Goals Advancing Our Strategy and Laying the Foundation for Sustainable Growth Continuously Improving Utility Safety Profile Moving forward with operational risk profile that's greatly improved since the 2023 Maui wildfires. 2025 - 2027 Wildfire Safety Strategy awaits PUC approval. Tort Litigation Settlement Agreement Progressing as Exp ...
Endeavour Silver(EXK) - 2025 Q3 - Earnings Call Presentation
2025-11-07 18:00
Company Strategy & Growth - Endeavour Silver aims to become a leading senior silver producer through organic growth and strategic acquisitions [17] - The company targets production of 30 million ounces of silver equivalent (AgEq) by 2030, dubbed "30 by 30" [16] - Endeavour Silver strategically acquires key assets, exemplified by the acquisition of the Kolpa mine in Peru [14, 24] Production & Operations - YTD 2025 production reached 74 million ounces AgEq [19] - Guanaceví contributed 52% to YTD 2025 metal sales quantity, followed by Kolpa at 20% and Bolañitos at 28% [20] - Terronera mine commenced commercial production on October 1, 2025, with average daily production of 1,841 tonnes in July [18, 43, 52] Kolpa Mine Acquisition - The Kolpa mine acquisition is expected to increase Endeavour's annual production profile by approximately 50 million ounces AgEq [25] - Since May 1, 2025, Kolpa has produced 209 million ounces AgEq [22] - In Q3 2025, Kolpa produced 598,689 ounces of silver, 5,664 tonnes of lead, 3,666 tonnes of zinc, and 120 tonnes of copper [29] Pitarrilla Project - Endeavour Silver is advancing an economic study for the Pitarrilla project, one of the world's largest undeveloped silver deposits [18, 60] - In 2025, an estimated $257 million is allocated for Pitarrilla, including $166 million for feasibility study, development, and exploration [18] - Pitarrilla's resource mix is 60% silver and 40% lead/zinc [59]
CNH Industrial N.V.(CNH) - 2025 Q3 - Earnings Call Presentation
2025-11-07 16:30
Financial Performance - Consolidated revenues decreased by 5% year-over-year to $4.4 billion[11] - Industrial Activities net sales decreased by 7% year-over-year to $3.7 billion[11] - Industrial Activities adjusted EBIT decreased by 69% year-over-year to $104 million[11] - Net income decreased by 78% year-over-year to $67 million[11] - Adjusted diluted EPS decreased by $0.16 to $0.08[11] Segment Results - Agriculture net sales decreased by 10% year-over-year to $2.963 billion[28] - Agriculture adjusted EBIT decreased by $200 million to $136 million[28] - Construction net sales increased by 8% year-over-year to $739 million[30] - Construction adjusted EBIT decreased by $26 million to $14 million[31] - Financial Services Q3 retail originations decreased by $0.2 billion year-over-year to $2.7 billion[34] - Financial Services managed portfolio decreased by $0.5 billion year-over-year to $28.5 billion[34] Outlook - Agriculture industry retail demand forecast is expected to decrease by 13%-11% year-over-year[39] - Agriculture net sales are expected to be $14.0 billion[39] - Construction industry retail demand forecast is expected to decrease by 5%-3% year-over-year[41] - Construction net sales are expected to be $3.1 billion[41]
Franklin Resources(BEN) - 2025 Q4 - Earnings Call Presentation
2025-11-07 16:00
AUM and Flows - Ending AUM was $16612 billion, a decrease of 1% compared to the prior year[7,9,11] - Long-term inflows increased 78% year-over-year to $3439 billion[7,48] - Long-term net outflows were $974 billion, compared to $326 billion in the prior year[7] - Excluding Western Asset Management, long-term net inflows were $445 billion, compared to $160 billion in the prior year[7] - ETF AUM increased by 56% to $491 billion with $137 billion of net inflows[7] - Retail SMA AUM increased by 13% to $1645 billion with $27 billion in net inflows[7] - Canvas® AUM increased by 71% to $163 billion with $47 billion of net inflows[7] Financial Performance - Adjusted revenue increased 21% year-over-year to $67011 million[9,11,12] - Adjusted operating income decreased 43% year-over-year to $16402 million[9,11,12] - Adjusted net income decreased 63% year-over-year to $11958 million[9,11,12] - Adjusted diluted EPS decreased 75% year-over-year to $222[9,11,12] Alternatives - Alternative AUM increased to $2639 billion after $139 billion in realizations and distributions[7] - Fundraised $262 billion in alternatives, including $229 billion in private markets[7,17] Capital Management - Returned $930 million to shareholders through dividends ($690 million) and share repurchases ($240 million)[15] - Cash and investments totaled $674 billion[10,12]